Global Personalized Medicines In Oncology Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
According to our (Global Info Research) latest study, the global Personalized Medicines In Oncology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Personalized Medicines In Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Personalized Medicines In Oncology market size and forecasts, in consumption value ($ Million), 2018-2029
Global Personalized Medicines In Oncology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Personalized Medicines In Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Personalized Medicines In Oncology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Personalized Medicines In Oncology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Personalized Medicines In Oncology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biotheranostics, Illumina, DNA Link, Genomic Health, Inc.(Exact Sciences) and Cypher Genomics(Human Longevity, Inc.), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Personalized Medicines In Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Personalized Medicines In Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Medicines In Oncology, with revenue, gross margin and global market share of Personalized Medicines In Oncology from 2018 to 2023.
Chapter 3, the Personalized Medicines In Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Personalized Medicines In Oncology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Medicines In Oncology.
Chapter 13, to describe Personalized Medicines In Oncology research findings and conclusion.
According to our (Global Info Research) latest study, the global Personalized Medicines In Oncology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Personalized Medicines In Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Personalized Medicines In Oncology market size and forecasts, in consumption value ($ Million), 2018-2029
Global Personalized Medicines In Oncology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Personalized Medicines In Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Personalized Medicines In Oncology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Personalized Medicines In Oncology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Personalized Medicines In Oncology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biotheranostics, Illumina, DNA Link, Genomic Health, Inc.(Exact Sciences) and Cypher Genomics(Human Longevity, Inc.), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Personalized Medicines In Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Molecular Oncopathology
- Genome Diagnostics
- Radiation Therapy
- Oncology Testing
- Chemotherapy
- Others
- Research Centers
- Governmental Institutions
- Hospitals
- Clinical Centers
- Others
- Biotheranostics
- Illumina
- DNA Link
- Genomic Health, Inc.(Exact Sciences)
- Cypher Genomics(Human Longevity, Inc.)
- Life Technologies Corporation(Thermo Fisher Scientific)
- Fulgent Genetics
- Caris Life Sciences
- Ariana Pharma
- Abbott Laboratories
- deCODE genetics
- Exagen Inc
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Personalized Medicines In Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Medicines In Oncology, with revenue, gross margin and global market share of Personalized Medicines In Oncology from 2018 to 2023.
Chapter 3, the Personalized Medicines In Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Personalized Medicines In Oncology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Medicines In Oncology.
Chapter 13, to describe Personalized Medicines In Oncology research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Personalized Medicines In Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Medicines In Oncology by Type
1.3.1 Overview: Global Personalized Medicines In Oncology Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Personalized Medicines In Oncology Consumption Value Market Share by Type in 2022
1.3.3 Molecular Oncopathology
1.3.4 Genome Diagnostics
1.3.5 Radiation Therapy
1.3.6 Oncology Testing
1.3.7 Chemotherapy
1.3.8 Others
1.4 Global Personalized Medicines In Oncology Market by Application
1.4.1 Overview: Global Personalized Medicines In Oncology Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Research Centers
1.4.3 Governmental Institutions
1.4.4 Hospitals
1.4.5 Clinical Centers
1.4.6 Others
1.5 Global Personalized Medicines In Oncology Market Size & Forecast
1.6 Global Personalized Medicines In Oncology Market Size and Forecast by Region
1.6.1 Global Personalized Medicines In Oncology Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Personalized Medicines In Oncology Market Size by Region, (2018-2029)
1.6.3 North America Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.4 Europe Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.6 South America Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Biotheranostics
2.1.1 Biotheranostics Details
2.1.2 Biotheranostics Major Business
2.1.3 Biotheranostics Personalized Medicines In Oncology Product and Solutions
2.1.4 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biotheranostics Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Personalized Medicines In Oncology Product and Solutions
2.2.4 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 DNA Link
2.3.1 DNA Link Details
2.3.2 DNA Link Major Business
2.3.3 DNA Link Personalized Medicines In Oncology Product and Solutions
2.3.4 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DNA Link Recent Developments and Future Plans
2.4 Genomic Health, Inc.(Exact Sciences)
2.4.1 Genomic Health, Inc.(Exact Sciences) Details
2.4.2 Genomic Health, Inc.(Exact Sciences) Major Business
2.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product and Solutions
2.4.4 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Genomic Health, Inc.(Exact Sciences) Recent Developments and Future Plans
2.5 Cypher Genomics(Human Longevity, Inc.)
2.5.1 Cypher Genomics(Human Longevity, Inc.) Details
2.5.2 Cypher Genomics(Human Longevity, Inc.) Major Business
2.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product and Solutions
2.5.4 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Developments and Future Plans
2.6 Life Technologies Corporation(Thermo Fisher Scientific)
2.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Details
2.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Major Business
2.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product and Solutions
2.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Developments and Future Plans
2.7 Fulgent Genetics
2.7.1 Fulgent Genetics Details
2.7.2 Fulgent Genetics Major Business
2.7.3 Fulgent Genetics Personalized Medicines In Oncology Product and Solutions
2.7.4 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fulgent Genetics Recent Developments and Future Plans
2.8 Caris Life Sciences
2.8.1 Caris Life Sciences Details
2.8.2 Caris Life Sciences Major Business
2.8.3 Caris Life Sciences Personalized Medicines In Oncology Product and Solutions
2.8.4 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Caris Life Sciences Recent Developments and Future Plans
2.9 Ariana Pharma
2.9.1 Ariana Pharma Details
2.9.2 Ariana Pharma Major Business
2.9.3 Ariana Pharma Personalized Medicines In Oncology Product and Solutions
2.9.4 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ariana Pharma Recent Developments and Future Plans
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Personalized Medicines In Oncology Product and Solutions
2.10.4 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Laboratories Recent Developments and Future Plans
2.11 deCODE genetics
2.11.1 deCODE genetics Details
2.11.2 deCODE genetics Major Business
2.11.3 deCODE genetics Personalized Medicines In Oncology Product and Solutions
2.11.4 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 deCODE genetics Recent Developments and Future Plans
2.12 Exagen Inc
2.12.1 Exagen Inc Details
2.12.2 Exagen Inc Major Business
2.12.3 Exagen Inc Personalized Medicines In Oncology Product and Solutions
2.12.4 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Exagen Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Personalized Medicines In Oncology Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Personalized Medicines In Oncology by Company Revenue
3.2.2 Top 3 Personalized Medicines In Oncology Players Market Share in 2022
3.2.3 Top 6 Personalized Medicines In Oncology Players Market Share in 2022
3.3 Personalized Medicines In Oncology Market: Overall Company Footprint Analysis
3.3.1 Personalized Medicines In Oncology Market: Region Footprint
3.3.2 Personalized Medicines In Oncology Market: Company Product Type Footprint
3.3.3 Personalized Medicines In Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Personalized Medicines In Oncology Consumption Value and Market Share by Type (2018-2023)
4.2 Global Personalized Medicines In Oncology Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2023)
5.2 Global Personalized Medicines In Oncology Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
6.2 North America Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
6.3 North America Personalized Medicines In Oncology Market Size by Country
6.3.1 North America Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
6.3.2 United States Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
6.3.3 Canada Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
6.3.4 Mexico Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
7.2 Europe Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
7.3 Europe Personalized Medicines In Oncology Market Size by Country
7.3.1 Europe Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
7.3.2 Germany Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.3 France Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.5 Russia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.6 Italy Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region
8.3.1 Asia-Pacific Personalized Medicines In Oncology Consumption Value by Region (2018-2029)
8.3.2 China Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.3 Japan Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.4 South Korea Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.5 India Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.7 Australia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
9.2 South America Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
9.3 South America Personalized Medicines In Oncology Market Size by Country
9.3.1 South America Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
9.3.2 Brazil Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
9.3.3 Argentina Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country
10.3.1 Middle East & Africa Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
10.3.2 Turkey Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
10.3.4 UAE Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Personalized Medicines In Oncology Market Drivers
11.2 Personalized Medicines In Oncology Market Restraints
11.3 Personalized Medicines In Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Personalized Medicines In Oncology Industry Chain
12.2 Personalized Medicines In Oncology Upstream Analysis
12.3 Personalized Medicines In Oncology Midstream Analysis
12.4 Personalized Medicines In Oncology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Personalized Medicines In Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Personalized Medicines In Oncology by Type
1.3.1 Overview: Global Personalized Medicines In Oncology Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Personalized Medicines In Oncology Consumption Value Market Share by Type in 2022
1.3.3 Molecular Oncopathology
1.3.4 Genome Diagnostics
1.3.5 Radiation Therapy
1.3.6 Oncology Testing
1.3.7 Chemotherapy
1.3.8 Others
1.4 Global Personalized Medicines In Oncology Market by Application
1.4.1 Overview: Global Personalized Medicines In Oncology Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Research Centers
1.4.3 Governmental Institutions
1.4.4 Hospitals
1.4.5 Clinical Centers
1.4.6 Others
1.5 Global Personalized Medicines In Oncology Market Size & Forecast
1.6 Global Personalized Medicines In Oncology Market Size and Forecast by Region
1.6.1 Global Personalized Medicines In Oncology Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Personalized Medicines In Oncology Market Size by Region, (2018-2029)
1.6.3 North America Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.4 Europe Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.6 South America Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Personalized Medicines In Oncology Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Biotheranostics
2.1.1 Biotheranostics Details
2.1.2 Biotheranostics Major Business
2.1.3 Biotheranostics Personalized Medicines In Oncology Product and Solutions
2.1.4 Biotheranostics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biotheranostics Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Personalized Medicines In Oncology Product and Solutions
2.2.4 Illumina Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 DNA Link
2.3.1 DNA Link Details
2.3.2 DNA Link Major Business
2.3.3 DNA Link Personalized Medicines In Oncology Product and Solutions
2.3.4 DNA Link Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DNA Link Recent Developments and Future Plans
2.4 Genomic Health, Inc.(Exact Sciences)
2.4.1 Genomic Health, Inc.(Exact Sciences) Details
2.4.2 Genomic Health, Inc.(Exact Sciences) Major Business
2.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product and Solutions
2.4.4 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Genomic Health, Inc.(Exact Sciences) Recent Developments and Future Plans
2.5 Cypher Genomics(Human Longevity, Inc.)
2.5.1 Cypher Genomics(Human Longevity, Inc.) Details
2.5.2 Cypher Genomics(Human Longevity, Inc.) Major Business
2.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product and Solutions
2.5.4 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Developments and Future Plans
2.6 Life Technologies Corporation(Thermo Fisher Scientific)
2.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Details
2.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Major Business
2.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product and Solutions
2.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Developments and Future Plans
2.7 Fulgent Genetics
2.7.1 Fulgent Genetics Details
2.7.2 Fulgent Genetics Major Business
2.7.3 Fulgent Genetics Personalized Medicines In Oncology Product and Solutions
2.7.4 Fulgent Genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Fulgent Genetics Recent Developments and Future Plans
2.8 Caris Life Sciences
2.8.1 Caris Life Sciences Details
2.8.2 Caris Life Sciences Major Business
2.8.3 Caris Life Sciences Personalized Medicines In Oncology Product and Solutions
2.8.4 Caris Life Sciences Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Caris Life Sciences Recent Developments and Future Plans
2.9 Ariana Pharma
2.9.1 Ariana Pharma Details
2.9.2 Ariana Pharma Major Business
2.9.3 Ariana Pharma Personalized Medicines In Oncology Product and Solutions
2.9.4 Ariana Pharma Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ariana Pharma Recent Developments and Future Plans
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Personalized Medicines In Oncology Product and Solutions
2.10.4 Abbott Laboratories Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Abbott Laboratories Recent Developments and Future Plans
2.11 deCODE genetics
2.11.1 deCODE genetics Details
2.11.2 deCODE genetics Major Business
2.11.3 deCODE genetics Personalized Medicines In Oncology Product and Solutions
2.11.4 deCODE genetics Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 deCODE genetics Recent Developments and Future Plans
2.12 Exagen Inc
2.12.1 Exagen Inc Details
2.12.2 Exagen Inc Major Business
2.12.3 Exagen Inc Personalized Medicines In Oncology Product and Solutions
2.12.4 Exagen Inc Personalized Medicines In Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Exagen Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Personalized Medicines In Oncology Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Personalized Medicines In Oncology by Company Revenue
3.2.2 Top 3 Personalized Medicines In Oncology Players Market Share in 2022
3.2.3 Top 6 Personalized Medicines In Oncology Players Market Share in 2022
3.3 Personalized Medicines In Oncology Market: Overall Company Footprint Analysis
3.3.1 Personalized Medicines In Oncology Market: Region Footprint
3.3.2 Personalized Medicines In Oncology Market: Company Product Type Footprint
3.3.3 Personalized Medicines In Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Personalized Medicines In Oncology Consumption Value and Market Share by Type (2018-2023)
4.2 Global Personalized Medicines In Oncology Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2023)
5.2 Global Personalized Medicines In Oncology Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
6.2 North America Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
6.3 North America Personalized Medicines In Oncology Market Size by Country
6.3.1 North America Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
6.3.2 United States Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
6.3.3 Canada Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
6.3.4 Mexico Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
7.2 Europe Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
7.3 Europe Personalized Medicines In Oncology Market Size by Country
7.3.1 Europe Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
7.3.2 Germany Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.3 France Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.5 Russia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
7.3.6 Italy Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region
8.3.1 Asia-Pacific Personalized Medicines In Oncology Consumption Value by Region (2018-2029)
8.3.2 China Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.3 Japan Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.4 South Korea Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.5 India Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
8.3.7 Australia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
9.2 South America Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
9.3 South America Personalized Medicines In Oncology Market Size by Country
9.3.1 South America Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
9.3.2 Brazil Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
9.3.3 Argentina Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Personalized Medicines In Oncology Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Personalized Medicines In Oncology Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country
10.3.1 Middle East & Africa Personalized Medicines In Oncology Consumption Value by Country (2018-2029)
10.3.2 Turkey Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
10.3.4 UAE Personalized Medicines In Oncology Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Personalized Medicines In Oncology Market Drivers
11.2 Personalized Medicines In Oncology Market Restraints
11.3 Personalized Medicines In Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Personalized Medicines In Oncology Industry Chain
12.2 Personalized Medicines In Oncology Upstream Analysis
12.3 Personalized Medicines In Oncology Midstream Analysis
12.4 Personalized Medicines In Oncology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Personalized Medicines In Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Personalized Medicines In Oncology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Personalized Medicines In Oncology Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Personalized Medicines In Oncology Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Biotheranostics Company Information, Head Office, and Major Competitors
Table 6. Biotheranostics Major Business
Table 7. Biotheranostics Personalized Medicines In Oncology Product and Solutions
Table 8. Biotheranostics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Biotheranostics Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina Personalized Medicines In Oncology Product and Solutions
Table 13. Illumina Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. DNA Link Company Information, Head Office, and Major Competitors
Table 16. DNA Link Major Business
Table 17. DNA Link Personalized Medicines In Oncology Product and Solutions
Table 18. DNA Link Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. DNA Link Recent Developments and Future Plans
Table 20. Genomic Health, Inc.(Exact Sciences) Company Information, Head Office, and Major Competitors
Table 21. Genomic Health, Inc.(Exact Sciences) Major Business
Table 22. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product and Solutions
Table 23. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Genomic Health, Inc.(Exact Sciences) Recent Developments and Future Plans
Table 25. Cypher Genomics(Human Longevity, Inc.) Company Information, Head Office, and Major Competitors
Table 26. Cypher Genomics(Human Longevity, Inc.) Major Business
Table 27. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product and Solutions
Table 28. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Cypher Genomics(Human Longevity, Inc.) Recent Developments and Future Plans
Table 30. Life Technologies Corporation(Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 31. Life Technologies Corporation(Thermo Fisher Scientific) Major Business
Table 32. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product and Solutions
Table 33. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Life Technologies Corporation(Thermo Fisher Scientific) Recent Developments and Future Plans
Table 35. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 36. Fulgent Genetics Major Business
Table 37. Fulgent Genetics Personalized Medicines In Oncology Product and Solutions
Table 38. Fulgent Genetics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Fulgent Genetics Recent Developments and Future Plans
Table 40. Caris Life Sciences Company Information, Head Office, and Major Competitors
Table 41. Caris Life Sciences Major Business
Table 42. Caris Life Sciences Personalized Medicines In Oncology Product and Solutions
Table 43. Caris Life Sciences Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Caris Life Sciences Recent Developments and Future Plans
Table 45. Ariana Pharma Company Information, Head Office, and Major Competitors
Table 46. Ariana Pharma Major Business
Table 47. Ariana Pharma Personalized Medicines In Oncology Product and Solutions
Table 48. Ariana Pharma Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Ariana Pharma Recent Developments and Future Plans
Table 50. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 51. Abbott Laboratories Major Business
Table 52. Abbott Laboratories Personalized Medicines In Oncology Product and Solutions
Table 53. Abbott Laboratories Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Abbott Laboratories Recent Developments and Future Plans
Table 55. deCODE genetics Company Information, Head Office, and Major Competitors
Table 56. deCODE genetics Major Business
Table 57. deCODE genetics Personalized Medicines In Oncology Product and Solutions
Table 58. deCODE genetics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. deCODE genetics Recent Developments and Future Plans
Table 60. Exagen Inc Company Information, Head Office, and Major Competitors
Table 61. Exagen Inc Major Business
Table 62. Exagen Inc Personalized Medicines In Oncology Product and Solutions
Table 63. Exagen Inc Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Exagen Inc Recent Developments and Future Plans
Table 65. Global Personalized Medicines In Oncology Revenue (USD Million) by Players (2018-2023)
Table 66. Global Personalized Medicines In Oncology Revenue Share by Players (2018-2023)
Table 67. Breakdown of Personalized Medicines In Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Personalized Medicines In Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Personalized Medicines In Oncology Players
Table 70. Personalized Medicines In Oncology Market: Company Product Type Footprint
Table 71. Personalized Medicines In Oncology Market: Company Product Application Footprint
Table 72. Personalized Medicines In Oncology New Market Entrants and Barriers to Market Entry
Table 73. Personalized Medicines In Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Personalized Medicines In Oncology Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Personalized Medicines In Oncology Consumption Value Share by Type (2018-2023)
Table 76. Global Personalized Medicines In Oncology Consumption Value Forecast by Type (2024-2029)
Table 77. Global Personalized Medicines In Oncology Consumption Value by Application (2018-2023)
Table 78. Global Personalized Medicines In Oncology Consumption Value Forecast by Application (2024-2029)
Table 79. North America Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Personalized Medicines In Oncology Raw Material
Table 110. Key Suppliers of Personalized Medicines In Oncology Raw Materials
Table 1. Global Personalized Medicines In Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Personalized Medicines In Oncology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Personalized Medicines In Oncology Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Personalized Medicines In Oncology Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Biotheranostics Company Information, Head Office, and Major Competitors
Table 6. Biotheranostics Major Business
Table 7. Biotheranostics Personalized Medicines In Oncology Product and Solutions
Table 8. Biotheranostics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Biotheranostics Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina Personalized Medicines In Oncology Product and Solutions
Table 13. Illumina Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. DNA Link Company Information, Head Office, and Major Competitors
Table 16. DNA Link Major Business
Table 17. DNA Link Personalized Medicines In Oncology Product and Solutions
Table 18. DNA Link Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. DNA Link Recent Developments and Future Plans
Table 20. Genomic Health, Inc.(Exact Sciences) Company Information, Head Office, and Major Competitors
Table 21. Genomic Health, Inc.(Exact Sciences) Major Business
Table 22. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product and Solutions
Table 23. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Genomic Health, Inc.(Exact Sciences) Recent Developments and Future Plans
Table 25. Cypher Genomics(Human Longevity, Inc.) Company Information, Head Office, and Major Competitors
Table 26. Cypher Genomics(Human Longevity, Inc.) Major Business
Table 27. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product and Solutions
Table 28. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Cypher Genomics(Human Longevity, Inc.) Recent Developments and Future Plans
Table 30. Life Technologies Corporation(Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 31. Life Technologies Corporation(Thermo Fisher Scientific) Major Business
Table 32. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product and Solutions
Table 33. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Life Technologies Corporation(Thermo Fisher Scientific) Recent Developments and Future Plans
Table 35. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 36. Fulgent Genetics Major Business
Table 37. Fulgent Genetics Personalized Medicines In Oncology Product and Solutions
Table 38. Fulgent Genetics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Fulgent Genetics Recent Developments and Future Plans
Table 40. Caris Life Sciences Company Information, Head Office, and Major Competitors
Table 41. Caris Life Sciences Major Business
Table 42. Caris Life Sciences Personalized Medicines In Oncology Product and Solutions
Table 43. Caris Life Sciences Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Caris Life Sciences Recent Developments and Future Plans
Table 45. Ariana Pharma Company Information, Head Office, and Major Competitors
Table 46. Ariana Pharma Major Business
Table 47. Ariana Pharma Personalized Medicines In Oncology Product and Solutions
Table 48. Ariana Pharma Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Ariana Pharma Recent Developments and Future Plans
Table 50. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 51. Abbott Laboratories Major Business
Table 52. Abbott Laboratories Personalized Medicines In Oncology Product and Solutions
Table 53. Abbott Laboratories Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Abbott Laboratories Recent Developments and Future Plans
Table 55. deCODE genetics Company Information, Head Office, and Major Competitors
Table 56. deCODE genetics Major Business
Table 57. deCODE genetics Personalized Medicines In Oncology Product and Solutions
Table 58. deCODE genetics Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. deCODE genetics Recent Developments and Future Plans
Table 60. Exagen Inc Company Information, Head Office, and Major Competitors
Table 61. Exagen Inc Major Business
Table 62. Exagen Inc Personalized Medicines In Oncology Product and Solutions
Table 63. Exagen Inc Personalized Medicines In Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Exagen Inc Recent Developments and Future Plans
Table 65. Global Personalized Medicines In Oncology Revenue (USD Million) by Players (2018-2023)
Table 66. Global Personalized Medicines In Oncology Revenue Share by Players (2018-2023)
Table 67. Breakdown of Personalized Medicines In Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Personalized Medicines In Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Personalized Medicines In Oncology Players
Table 70. Personalized Medicines In Oncology Market: Company Product Type Footprint
Table 71. Personalized Medicines In Oncology Market: Company Product Application Footprint
Table 72. Personalized Medicines In Oncology New Market Entrants and Barriers to Market Entry
Table 73. Personalized Medicines In Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Personalized Medicines In Oncology Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Personalized Medicines In Oncology Consumption Value Share by Type (2018-2023)
Table 76. Global Personalized Medicines In Oncology Consumption Value Forecast by Type (2024-2029)
Table 77. Global Personalized Medicines In Oncology Consumption Value by Application (2018-2023)
Table 78. Global Personalized Medicines In Oncology Consumption Value Forecast by Application (2024-2029)
Table 79. North America Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Personalized Medicines In Oncology Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Personalized Medicines In Oncology Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Personalized Medicines In Oncology Raw Material
Table 110. Key Suppliers of Personalized Medicines In Oncology Raw Materials
LIST OF FIGURES
Figure 1. Personalized Medicines In Oncology Picture
Figure 2. Global Personalized Medicines In Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Personalized Medicines In Oncology Consumption Value Market Share by Type in 2022
Figure 4. Molecular Oncopathology
Figure 5. Genome Diagnostics
Figure 6. Radiation Therapy
Figure 7. Oncology Testing
Figure 8. Chemotherapy
Figure 9. Others
Figure 10. Global Personalized Medicines In Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Personalized Medicines In Oncology Consumption Value Market Share by Application in 2022
Figure 12. Research Centers Picture
Figure 13. Governmental Institutions Picture
Figure 14. Hospitals Picture
Figure 15. Clinical Centers Picture
Figure 16. Others Picture
Figure 17. Global Personalized Medicines In Oncology Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Personalized Medicines In Oncology Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market Personalized Medicines In Oncology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global Personalized Medicines In Oncology Consumption Value Market Share by Region (2018-2029)
Figure 21. Global Personalized Medicines In Oncology Consumption Value Market Share by Region in 2022
Figure 22. North America Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Personalized Medicines In Oncology Revenue Share by Players in 2022
Figure 28. Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players Personalized Medicines In Oncology Market Share in 2022
Figure 30. Global Top 6 Players Personalized Medicines In Oncology Market Share in 2022
Figure 31. Global Personalized Medicines In Oncology Consumption Value Share by Type (2018-2023)
Figure 32. Global Personalized Medicines In Oncology Market Share Forecast by Type (2024-2029)
Figure 33. Global Personalized Medicines In Oncology Consumption Value Share by Application (2018-2023)
Figure 34. Global Personalized Medicines In Oncology Market Share Forecast by Application (2024-2029)
Figure 35. North America Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 36. North America Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 37. North America Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 42. Europe Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 45. France Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Personalized Medicines In Oncology Consumption Value Market Share by Region (2018-2029)
Figure 52. China Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 55. India Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 58. South America Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 59. South America Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 60. South America Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 64. Middle East and Africa Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 69. Personalized Medicines In Oncology Market Drivers
Figure 70. Personalized Medicines In Oncology Market Restraints
Figure 71. Personalized Medicines In Oncology Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Personalized Medicines In Oncology in 2022
Figure 74. Manufacturing Process Analysis of Personalized Medicines In Oncology
Figure 75. Personalized Medicines In Oncology Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Figure 1. Personalized Medicines In Oncology Picture
Figure 2. Global Personalized Medicines In Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Personalized Medicines In Oncology Consumption Value Market Share by Type in 2022
Figure 4. Molecular Oncopathology
Figure 5. Genome Diagnostics
Figure 6. Radiation Therapy
Figure 7. Oncology Testing
Figure 8. Chemotherapy
Figure 9. Others
Figure 10. Global Personalized Medicines In Oncology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Personalized Medicines In Oncology Consumption Value Market Share by Application in 2022
Figure 12. Research Centers Picture
Figure 13. Governmental Institutions Picture
Figure 14. Hospitals Picture
Figure 15. Clinical Centers Picture
Figure 16. Others Picture
Figure 17. Global Personalized Medicines In Oncology Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Personalized Medicines In Oncology Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market Personalized Medicines In Oncology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global Personalized Medicines In Oncology Consumption Value Market Share by Region (2018-2029)
Figure 21. Global Personalized Medicines In Oncology Consumption Value Market Share by Region in 2022
Figure 22. North America Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Personalized Medicines In Oncology Revenue Share by Players in 2022
Figure 28. Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players Personalized Medicines In Oncology Market Share in 2022
Figure 30. Global Top 6 Players Personalized Medicines In Oncology Market Share in 2022
Figure 31. Global Personalized Medicines In Oncology Consumption Value Share by Type (2018-2023)
Figure 32. Global Personalized Medicines In Oncology Market Share Forecast by Type (2024-2029)
Figure 33. Global Personalized Medicines In Oncology Consumption Value Share by Application (2018-2023)
Figure 34. Global Personalized Medicines In Oncology Market Share Forecast by Application (2024-2029)
Figure 35. North America Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 36. North America Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 37. North America Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 42. Europe Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 45. France Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Personalized Medicines In Oncology Consumption Value Market Share by Region (2018-2029)
Figure 52. China Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 55. India Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 58. South America Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 59. South America Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 60. South America Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa Personalized Medicines In Oncology Consumption Value Market Share by Type (2018-2029)
Figure 64. Middle East and Africa Personalized Medicines In Oncology Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa Personalized Medicines In Oncology Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE Personalized Medicines In Oncology Consumption Value (2018-2029) & (USD Million)
Figure 69. Personalized Medicines In Oncology Market Drivers
Figure 70. Personalized Medicines In Oncology Market Restraints
Figure 71. Personalized Medicines In Oncology Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Personalized Medicines In Oncology in 2022
Figure 74. Manufacturing Process Analysis of Personalized Medicines In Oncology
Figure 75. Personalized Medicines In Oncology Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
